Study of Skin T-Cell Lymphoma Cases and Treatments
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study reviews medical records of patients treated for cutaneous T-cell lymphoma (a type of blood cancer affecting the skin) at Hospital México in Costa Rica. Researchers will examine how the disease is diagnosed, staged, and treated to better understand patterns and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Confirmed diagnosis of cutaneous T-cell lymphoma (skin T-cell lymphoma) confirmed by biopsy and lab testing
- Age 18 years or older
- Received care at Hospital México's Dermatology Service between January 2019 and December 2025
- Had at least one skin doctor visit during the study period
- Received treatment for your condition, such as light therapy, skin creams, radiation, or systemic medications
- Complete and clear medical records available for review
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry for people with certain T-cell or NK-cell lymphomas. It collects health information and tumor samples to learn more about these diseases and improve future treatments.
This study looks at what treatments work for people with primary cutaneous lymphoma, and how patients do over time. It uses real patient information from participating hospitals to understand outcomes after diagnosis.
This study looks at why skin lymphomas behave differently from person to person and may identify new targets for treatment. You may be invited if you have (or are being evaluated for) a suspected or confirmed skin lymphoma.
This study looks at the bacteria (microbiome) living on the skin in people with specific skin conditions, and in healthy volunteers. The results may help researchers understand what skin microbes have to do with these diseases.
This trial looks at the results of different systemic (whole-body) treatments for cutaneous T-cell lymphoma (CTCL), a rare type of lymphoma that affects the skin. It aims to understand how well these therapies work and help guide future treatment choices.
This study collects stored tissue samples (from skin or other needed procedures) from people with CTCL, Sézary syndrome, or lymphomatoid papulosis, especially when you are starting or changing treatment. It’s meant to help researchers learn more about these illnesses and may support future research.
Hear when a new T-cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.